Cargando…
Retraction
Retraction: Yang, Y, Zheng, J, Wang, M, et al. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling. Cancer Sci. 2021; 112: 641–654. https://doi.org/10.1111/cas.14744. The above article, published online on 22 November 2020 in Wiley Online Library (wile...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323109/ https://www.ncbi.nlm.nih.gov/pubmed/37211924 http://dx.doi.org/10.1111/cas.15809 |
_version_ | 1785068897667383296 |
---|---|
collection | PubMed |
description | Retraction: Yang, Y, Zheng, J, Wang, M, et al. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling. Cancer Sci. 2021; 112: 641–654. https://doi.org/10.1111/cas.14744. The above article, published online on 22 November 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor‐in‐Chief, Masanori Hatakeyama, the Japanese Cancer Association and John Wiley and Sons Australia, Ltd. The retraction has been agreed following concerns raised by a third party about figures within the article. During the journal's investigation into the concerns raised, the authors were not able to provide comprehensive original data for the figures in concern. Accordingly, the editorial team considers the conclusions of this manuscript insufficiently supported. |
format | Online Article Text |
id | pubmed-10323109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103231092023-07-07 Retraction Cancer Sci Retraction Retraction: Yang, Y, Zheng, J, Wang, M, et al. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling. Cancer Sci. 2021; 112: 641–654. https://doi.org/10.1111/cas.14744. The above article, published online on 22 November 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor‐in‐Chief, Masanori Hatakeyama, the Japanese Cancer Association and John Wiley and Sons Australia, Ltd. The retraction has been agreed following concerns raised by a third party about figures within the article. During the journal's investigation into the concerns raised, the authors were not able to provide comprehensive original data for the figures in concern. Accordingly, the editorial team considers the conclusions of this manuscript insufficiently supported. John Wiley and Sons Inc. 2023-05-22 /pmc/articles/PMC10323109/ /pubmed/37211924 http://dx.doi.org/10.1111/cas.15809 Text en © 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Retraction Retraction |
title | Retraction |
title_full | Retraction |
title_fullStr | Retraction |
title_full_unstemmed | Retraction |
title_short | Retraction |
title_sort | retraction |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323109/ https://www.ncbi.nlm.nih.gov/pubmed/37211924 http://dx.doi.org/10.1111/cas.15809 |